Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797602 · ClinicalTrials.gov registry record
Proton Therapy for Chordomas and/or Chondrosarcomas
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 189
- Enrollment target
NCT00797602: Completed study, sponsored by University of Florida.
NCT00797602 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 189 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00797602 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 189 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2007-01 |
| Est. Completion | 2015-12 |
What the finished NCT00797602 record still lists
NCT00797602 is an observational study that tracks outcomes without assigning an intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00797602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00797602 about?
NCT00797602 is a clinical study titled "Proton Therapy for Chordomas and/or Chondrosarcomas". The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.
What is the current status of trial NCT00797602?
This trial is currently completed. The enrollment target is 189 participants. The study started on 2007-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00797602?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia